photo of

Details

Role Group Leader / Snr Princ Research Fellow
Research area Infection, Immunity and Global Health
Group Enteric Diseases

Top Publications

  • At Thobari, J, Damayanti, W, Haposan, JH, Nirwati, H, Iskandar, K, Samad, Fahmi, J, Sari, RM, Bachtiar, NS, Watts, E, et al. Safety and immunogenicity of human neonatal RV3 rotavirus vaccine (Bio Farma) in adults, children, and neonates in Indonesia: Phase I Trial. Vaccine 39(33) : 4651 -4658 2021
    view publication
  • Hamidi, A, Hoeksema, F, Velthof, P, Lemckert, A, Gillissen, G, Luitjens, A, Bines, JE, Pullagurla, SR, Kumar, P, Volkin, DB, et al. Developing a manufacturing process to deliver a cost effective and stable liquid human rotavirus vaccine. Vaccine 39(15) : 2048 -2059 2021
    view publication
  • Kumar, P, Pullagurla, SR, Patel, A, Shukla, RS, Bird, C, Kumru, OS, Hamidi, A, Hoeksema, F, Yallop, C, Bines, JE, et al. Effect of Formulation Variables on the Stability of a Live, Rotavirus (RV3-BB) Vaccine Candidate using in vitro Gastric Digestion Models to Mimic Oral Delivery. Journal of Pharmaceutical Sciences 110(2) : 760 -770 2021
    view publication
  • Jenney, AWJ, Reyburn, R, Ratu, FT, Tuivaga, E, Nguyen, C, Covea, S, Thomas, S, Rafai, E, Devi, R, Bright, K, et al. The impact of the rotavirus vaccine on diarrhoea, five years following national introduction in Fiji. The Lancet Regional Health - Western Pacific 6: 100053 2021
    view publication
  • Witte, D, Handley, A, Jere, KC, Bogandovic-Sakran, N, Mpakiza, A, Turner, A, Pavlic, D, Boniface, K, Mandolo, J, Ong, DS, et al. Neonatal Rotavirus Vaccine (RV3-BB) Immunogenicity and Safety in a Neonatal and Infant Administration Schedule in Malawi: A Randomized, Double-Blind, Four-Arm Parallel Group Dose-Ranging Study. 2021
    view publication

Page 11 of 35

Related links